Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
NVO Novo Nordisk A/S daily Stock Chart
NVO [NYSE]
Novo Nordisk A/S
Healthcare | Biotechnology | Denmark
financial highlights | statements
Index- P/E20.90 EPS (ttm)2.43 Insider Own26.40% Shs Outstand1.99B Perf Week-0.33%
Market Cap100.81B Forward P/E18.35 EPS next Y2.76 Insider Trans0.00% Shs Float1.23B Perf Month2.13%
Income5.89B PEG2.35 EPS next Q0.63 Inst Own9.40% Short Float0.35% Perf Quarter13.04%
Sales17.05B P/S5.91 EPS this Y3.50% Inst Trans3.41% Short Ratio3.16 Perf Half Y7.91%
Book/sh3.29 P/B15.42 EPS next Y11.68% ROA37.70% Target Price49.41 Perf Year0.94%
Cash/sh- P/C- EPS next 5Y8.90% ROE80.20% 52W Range41.23 - 52.83 Perf YTD10.09%
Dividend1.27 P/FCF40.47 EPS past 5Y11.30% ROI73.10% 52W High-3.99% Beta0.61
Dividend %2.50% Quick Ratio0.80 Sales past 5Y6.00% Gross Margin84.20% 52W Low23.02% ATR0.67
Employees42672 Current Ratio1.10 Sales Q/Q6.20% Oper. Margin42.20% RSI (14)55.03 Volatility0.95% 0.92%
OptionableYes Debt/Eq0.01 EPS Q/Q5.30% Profit Margin34.50% Rel Volume0.99 Prev Close52.17
ShortableYes LT Debt/Eq0.00 EarningsMay 03 BMO Payout463.70% Avg Volume1.36M Price50.72
Recom3.00 SMA201.17% SMA503.51% SMA2007.59% Volume1,339,167 Change-2.78%
Jan-29-19Initiated Exane BNP Paribas Outperform
Dec-11-18Resumed Jefferies Hold
Oct-09-18Initiated Guggenheim Buy
Dec-29-17Upgrade JP Morgan Underweight → Neutral
Dec-06-17Upgrade BofA/Merrill Neutral → Buy
Dec-01-17Upgrade Morgan Stanley Equal-Weight → Overweight
Sep-25-17Downgrade Exane BNP Paribas Outperform → Neutral
Sep-06-17Upgrade BofA/Merrill Underperform → Neutral
Oct-31-16Downgrade DNB Markets Buy → Hold
Oct-31-16Downgrade Citigroup Buy → Neutral
Oct-28-16Downgrade BofA/Merrill Neutral → Underperform
Sep-23-16Initiated Piper Jaffray Neutral
Sep-13-16Upgrade Exane BNP Paribas Neutral → Outperform
Sep-09-16Downgrade JP Morgan Overweight → Neutral
Sep-01-16Downgrade Morgan Stanley Overweight → Equal-Weight
Aug-31-16Upgrade HSBC Securities Reduce → Hold
Aug-08-16Downgrade BofA/Merrill Buy → Neutral
Aug-28-15Initiated Leerink Partners Mkt Perform $56
Jun-09-15Upgrade Morgan Stanley Equal-Weight → Overweight
Apr-15-15Initiated Societe Generale Sell
Mar-22-19 06:01AM  Bull of the Day: DexCom (DXCM) Zacks
Mar-17-19 03:01AM  Novo Nordisk A/S (CPH:NOVO B): Ex-Dividend Is In 4 Days Simply Wall St.
Mar-06-19 09:24AM  REVIEWAPALOOZA!: 5-Stock Samplers Motley Fool
Mar-05-19 09:00AM  Lilly to Bring Half-Priced Version of Popular Humalog Insulin Zacks
Mar-04-19 08:58AM  What's in the Cards for Aeterna (AEZS) This Earnings Season? Zacks
Mar-01-19 07:00AM  Novo Nordisk files for a label update for Fiasp® to the EMA and the FDA seeking approval for use in children and adolescents PR Newswire
Feb-27-19 10:35AM  Ophthotech's (OPHT) Q4 Loss Wider, Gene Therapy in Focus Zacks
Feb-26-19 10:44AM  Strongbridge Biopharma plc (SBBP) Q4 2018 Earnings Conference Call Transcript Motley Fool
Feb-22-19 09:04AM  Pharma Stock Roundup: MRK Buys IMDZ, FDA Grants Priority Review to Some Candidates Zacks
Feb-21-19 10:08AM  Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)? Zacks
Feb-20-19 09:53AM  Novo Nordisk Gets FDA Nod for Haemophilia Drug Esperoct Zacks
Feb-12-19 05:30PM  Seattle Genetics' Adcetris Gets EC Nod for Label Expansion Zacks
Feb-11-19 07:30AM  Market Trends Toward New Normal in GameStop, Novo Nordisk A/S, Ferroglobe, PC Connection, Nanometrics, and Anavex Life Sciences Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
Feb-07-19 08:32AM  Sanofi (SNY) Q4 Earnings Top, Genzyme Unit Drives Sales Growth Zacks
02:00AM  [$$] Diabetes pill could inject insulin directly into stomach wall Financial Times
Feb-05-19 03:25PM  Novo Nordisk Is on the Upswing -- for Now Motley Fool
09:53AM  Sanofi's Myeloma Candidate Meets Goal in Phase III Study Zacks
09:19AM  Merck's Keytruda Clinches CHMP Nod for Difficult Lung Cancer Zacks
Feb-02-19 01:10AM  Novo Nordisk (NVO) Q4 2018 Earnings Conference Call Transcript Motley Fool
Feb-01-19 01:30PM  Attention Biotech Investors: Mark Your Calendar For These February PDUFA Dates Benzinga
12:44PM  [$$] Danish Drugmaker Expects Higher Working Capital as Brexit Looms The Wall Street Journal
12:13PM  Novo Nordisk (NVO) Q4 Earnings Miss Estimates, Revenues Beat Zacks
06:15AM  Novo Nordisk CEO backs ending drug industry rebate system Reuters
05:52AM  Novo Nordisk: 4Q Earnings Snapshot Associated Press
05:08AM  Novo Nordisk's new diabetes drug, outlook lift shares Reuters
04:44AM  Novo Nordisk's new diabetes drug, outlook lift shares Reuters
04:20AM  Novo Nordisk CEO Applauds Trump Plan to Limit Rebates Bloomberg
02:09AM  [$$] Novo Nordisk Net Profit Rise Misses Expectations The Wall Street Journal
Jan-31-19 09:52AM  Eli Lilly (LLY) Q4 Earnings Coming Up: What's in the Cards? Zacks
Jan-30-19 10:57AM  House Democratic leaders probe 3 major drugmakers on insulin prices CNBC
Jan-29-19 09:08AM  Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)? Zacks
Jan-28-19 09:55AM  Merck (MRK) Q4 Earnings Coming Up: What's in the Cards? Zacks
Jan-23-19 09:19AM  These 2 Biotech Stocks Seem Significantly Undervalued TheStreet.com
08:00AM  Xultophy® now available in Canada to support improved glycemic control, an issue facing 50 per cent of Canadians with type 2 diabetes CNW Group
Jan-22-19 03:24PM  5 Stocks With High Business Predictability Ratings GuruFocus.com
Jan-21-19 01:33PM  Lilly Stops Lartruvo Promotion as Confirmatory Study Fails Zacks
Jan-15-19 09:30PM  3 Top Diabetes Stocks to Watch in January Motley Fool
Jan-14-19 12:20PM  6 Bargain Stocks With Positive Earnings Growth Estimates GuruFocus.com
12:09PM  House Democrats launch drug-pricing probe into a dozen major health-care companies CNBC
Jan-11-19 05:36PM  5 Reasons Why Investors Should Buy Novo Nordisk (NVO) in 2019 Zacks
Jan-10-19 09:25PM  J&J raises U.S. prices on around two dozen drugs Reuters
06:49AM  [$$] Sanofi and Novo Nordisk press ahead with US insulin prices rises Financial Times
Jan-08-19 06:03PM  Thoughts on 2018 Performance GuruFocus.com
Jan-03-19 09:30AM  Novo Nordisk Boasts Strong Diabetes Presence and Pipeline Zacks
Dec-26-18 02:22PM  6 Valuable Pipeline Drugs With Upcoming Catalysts Benzinga
Dec-22-18 09:00AM  As obesity rates in America soar, new weight loss drugs are in the offing that offer hope CNBC
Dec-19-18 11:15AM  Strongbridge completes $181.7M sale of hormone drug to Novo Nordisk American City Business Journals
12:39AM  Here is What Hedge Funds Think About Novo Nordisk A/S (NVO) Insider Monkey
Dec-18-18 07:17AM  3 Biotechs With Potential Blockbusters Near the Finish Line Motley Fool
Dec-17-18 03:28PM  [$$] Staten Biotechnology Strikes $488 Million Deal With Novo The Wall Street Journal
Dec-05-18 08:53AM  Novo Nordisk announces another $22M investment in Clayton American City Business Journals
Nov-27-18 05:47PM  Zafgen (ZFGN) Plunges as FDA Puts Hold on Diabetes Drug Trial Zacks
Nov-21-18 08:15AM  The Zacks Analyst Blog Highlights: Sanofi, Novo Nordisk, NVIDIA, Fifth Third Bancorp and Continental Resources Zacks
Nov-14-18 06:53AM  Novo Nordisk A/S (NVO): Hedge Fund Sentiment Going Nowhere Insider Monkey
Nov-08-18 02:53PM  Novo Nordisk Continues Its Balancing Act Motley Fool
Nov-01-18 04:56PM  Novo Nordisk (NVO) Reports In-Line Q3 Earnings, Beats Sales Zacks
01:07PM  [$$] Danish Insulin Maker Novo Nordisk Cuts Jobs, Shifts R&D Spending The Wall Street Journal
12:36PM  Novo Nordisk (NVO) Q3 2018 Earnings Conference Call Transcript Motley Fool
05:59AM  Upbeat sales lift Novo Nordisk as drugmaker weathers U.S. pricing pressure Reuters
05:04AM  Novo Nordisk: 3Q Earnings Snapshot Associated Press
02:57AM  Novo Nordisk earnings miss expectations amid currency headwinds CNBC
Oct-31-18 02:56PM  Q3 Earnings Preview For Novo Nordisk Benzinga
Oct-26-18 08:45AM  Investor Expectations to Drive Momentum within Paratek Pharmaceuticals, Dell Technologies, Dover, Black Hills, Kinder Morgan, and Novo Nordisk A/S Discovering Underlying Factors of Influence GlobeNewswire
Oct-22-18 05:26PM  5 Undervalued Companies With Predictable Businesses GuruFocus.com
Oct-18-18 09:27AM  Novo Nordisk (NVO) Faces Pricing Pressure and Competition Zacks
Oct-16-18 08:50PM  Minnesota accuses insulin makers of deceptive drug pricing Reuters
05:10PM  Minnesota accuses insulin makers of deceptive drug pricing Reuters
Oct-15-18 04:37PM  6 Companies Growing Their Book Value GuruFocus.com
09:32AM  Novo Nordisk hires AstraZeneca executive to revive struggling biopharma unit Reuters
09:30AM  PFE or NVO: Which Is the Better Value Stock Right Now? Zacks
08:20AM  Novo Nordisk could close biopharma acquisition this year - CEO Reuters
Oct-08-18 07:30AM  The Week Ahead In Biotech: Conferences, Clinical Trial Results And IPOs Benzinga
Oct-05-18 09:54AM  Lilly's Novel Diabetes Candidate Shows Promise in Phase II Zacks
Oct-04-18 02:24PM  7 Healthcare Stocks to Buy Right Now InvestorPlace -7.35%
09:55AM  Lilly's diabetes drug data impresses, hurts rival Novo's shares Reuters
08:57AM  Diabetes Drug's Results Push Lilly to Look at Obesity Too Bloomberg
Sep-28-18 07:58AM  Novo Nordisk to cut 250 jobs in the United States Reuters
07:29AM  Novo Nordisk to cut 250 jobs in the United States Reuters
Sep-27-18 11:33AM  Investing in Diabetes Stocks: A Beginner's Guide Motley Fool
08:00AM  Government of Quebec provides adults living with diabetes mellitus access to ultra-long-acting insulin, TRESIBA® CNW Group
Sep-21-18 08:12AM  Ontario becomes first province to provide public funding of TRESIBA® for adults with diabetes mellitus CNW Group
Sep-19-18 08:48AM  Novo Nordisk to Restructure R&D Unit & Lay Off 400 Staff Zacks
Sep-18-18 02:06PM  Danish pharma giant Novo Nordisk to open first Mass. office American City Business Journals
05:11AM  Novo Nordisk lays off 400 staff in research & development unit Reuters
01:07AM  [$$] Novo Nordisk sheds 400 staff as it refocuses R&D efforts Financial Times
Sep-17-18 06:13PM  3 High-Quality Biotech Companies for 4th Quarter GuruFocus.com
Sep-14-18 02:04AM  Novo Nordisk CEO: Increasing inventories in anticipation ... CNBC Videos
Sep-12-18 06:00AM  EyePoint Pharmaceuticals Reports Fiscal 2018 Fourth Quarter & Full Year Financial Results and Highlights Recent Progress GlobeNewswire
Sep-10-18 07:00AM  EyePoint Pharmaceuticals Elects Göran Ando, M.D. as Next Chairman of Board of Directors GlobeNewswire
Sep-04-18 02:05PM  Novo Nordisk's Ozempic Lowers Risk of Cardiovascular Events (revised) Zacks
Aug-27-18 09:30AM  Novo Nordisk's Ozempic Lowers Risk of Cardiovascular Events Zacks
Aug-24-18 08:54AM  Pharma Stock Roundup: FDA Blow for AGN, Label Expansion Nod for MRK, BMY Cancer Drugs Zacks
Aug-20-18 04:47PM  Novo Nordisk Buys Ziylo to Develop Glucose Responsive Insulin Zacks
Aug-17-18 12:24AM  [$$] Novo Nordisk buys UK university biotech spin-out Ziylo Financial Times
Aug-14-18 04:22PM  Novo Nordisk's Pricing Pressures Aren't Going Away Motley Fool
Aug-13-18 07:38AM  The Zacks Analyst Blog Highlights: Novo Nordisk, J&J, Allergan, Editas, AstraZeneca, Merck and Bristol-Myers Zacks
Aug-10-18 11:18AM  Novo Nordisk (NVO) Q2 2018 Earnings Conference Call Transcript Motley Fool
08:52AM  Pharma Stock Roundup: NVO Q2 Earnings, JNJ, AGN & AZN's Pipeline Updates in Focus Zacks
08:08AM  Eli Lilly Stock History Motley Fool
Aug-08-18 11:12AM  Amazon, Novo Nordisk and Tesla are the Yahoo Finance charts of the day. Yahoo Finance Video -6.21%
Novo Nordisk A/S, a healthcare company, engages in the development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes Care and Obesity, and Biopharmaceuticals. The Diabetes Care and Obesity segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral anti-diabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company has a strategic alliance with Evotec AG to discover and develop small molecule therapies to treat patients suffering from diabetes, obesity, and co-morbidities, as well as has a research collaboration with Kallyope Inc. It also has a collaboration agreement Lund University to develop stem cell-derived treatment for Parkinson's diseases; and Staten Biotechnology B.V. to develop novel therapeutics for the treatment of dyslipidaemia. The company was founded in 1925 and is headquartered in Bagsvaerd, Denmark.
open in yahoo | open in reuters | open in google